Ligand Pharmaceuticals | 전 세금 이익

주가
198.31
매일 변경
2.14 1.09%
매월
4.25%
매년
62.24%
Q1 예상
192.24




전 세금 이익 변화 날짜
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Anika Therapeutics USD -3.87M 32.43M 2025-03
Arrowhead Research USD 28.27M 7.85M 2025-12
Baxter International USD 121M 12M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Enanta Pharmaceuticals USD -22.71M 95.08M 2024-12
Enviri Corporation USD 361.08M 15.18M 2025-09
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Glaxosmithkline GBP 2.46B 569M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -326.93M 41.77M 2025-12
Intrexon USD -60.48M 27.09M 2024-06
Ionis Pharmaceuticals USD -228M 99M 2025-12
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
MacroGenics USD 16.82M 52.97M 2025-09
Merck USD 6.74B 22M 2025-09
Pacira USD 9.52M 11.45M 2025-09
Pfizer USD 3.33B 290M 2025-09
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Veracyte USD 40.63M 21.74M 2025-12


Ligand Pharmaceuticals 전 세금 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2026.